Use of G-CSF for the extension of the therapeutic time-window of thrombolytic stroke therapy

Details for Australian Patent Application No. 2010216083 (hide)

Owner Sygnis Bioscience GmbH & Co. KG

Inventors Fisher, Marc; Schneider, Armin

Agent Pizzeys

Pub. Number AU-A-2010216083

PCT Pub. Number WO2010/096446

Priority 61/153,079 17.02.09 US

Filing date 17 February 2010

Wipo publication date 26 August 2010

International Classifications

A61K 38/19 (1970.01) Medicinal preparations containing peptides - Cytokines

Event Publications

18 August 2011 PCT application entered the National Phase

  PCT publication WO2010/096446 Priority application(s): WO2010/096446

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010216092-Membrane filter element with multiple fiber types

2010216068-Water purification and enhancement systems